Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President’s Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH12 121005CONT17

Opportunity Information: Apply for CDC RFA GH12 121005CONT17

This funding opportunity, titled "Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a U.S. government public health grant action administered by the U.S. Department of Health and Human Services through the Centers for Disease Control and Prevention (CDC), specifically CDC's Center for Global Health (CGH). The overall focus is HIV/AIDS programming in Nigeria, with an emphasis on strengthening and sustaining comprehensive clinical services that cover the full continuum of HIV prevention, care, and treatment. A central theme is engaging indigenous (locally based) organizations, which typically reflects PEPFAR's broader goal of building long-term country capacity, increasing local ownership of HIV response systems, and ensuring that clinical service delivery can be maintained and improved over time by Nigerian institutions.

The award mechanism is a cooperative agreement, which usually means the CDC expects to be substantially involved in the program beyond simply providing funds. In practical terms, cooperative agreements often include close technical collaboration, shared planning, performance monitoring, and active engagement between the recipient and CDC staff to ensure that program activities align with PEPFAR strategies, quality standards, and reporting requirements. The opportunity is listed as continuation funding, indicating it is intended to extend or continue work that is already underway rather than to launch an entirely new program from scratch. This typically suggests that recipients are expected to build on existing service delivery platforms, strengthen systems that are already operating, and maintain continuity of care for patients receiving HIV services.

Programmatically, the opportunity centers on comprehensive clinical services for HIV/AIDS in Nigeria. While the notice summary provided does not list specific interventions, "comprehensive clinical services" in the PEPFAR context generally includes HIV testing and counseling linked to care, antiretroviral therapy (ART) initiation and maintenance, viral load monitoring and clinical follow-up, prevention and management of opportunistic infections (including TB/HIV integration), prevention of mother-to-child transmission (PMTCT) services, adherence support and differentiated service delivery models, and efforts to improve retention in care and treatment outcomes. On the prevention side, clinical prevention services can include testing and linkage approaches, prevention counseling, and other evidence-based interventions typically aligned with national guidelines and PEPFAR priorities. Because the title explicitly emphasizes sustaining and enhancing services, the intent is not only to provide direct clinical care but also to reinforce the operational and quality components that keep programs effective, such as clinical mentorship, laboratory and supply chain coordination, data systems, and continuous quality improvement.

Eligibility is broadly labeled as "Others," with a note to consult additional eligibility language in the full announcement. Even without that extra text, the opportunity title and framing around indigenous organizations strongly implies a preference or requirement for Nigerian local organizations, such as local non-governmental organizations, indigenous health partners, or other in-country entities capable of managing clinical HIV programs. This focus aligns with the long-running PEPFAR emphasis on transitioning program leadership and implementation capacity to local partners, strengthening governance, and ensuring that services are more sustainable and responsive to local contexts.

From an administrative standpoint, the funding opportunity number is CDC RFA GH12-121005CONT17, and the program is categorized under health with CFDA number 93.067, which is commonly associated with HIV-related CDC global activities supported under PEPFAR. The opportunity was created on February 6, 2017, with an original closing date of April 6, 2017, which indicates a standard application window for continuation or renewal actions. The listing notes an expected 10 awards, suggesting that CDC anticipated supporting multiple implementing partners or multiple geographic or programmatic portfolios within Nigeria under this continuation framework.

The award ceiling is shown as 0, which in federal grant listings often means the ceiling is unspecified in the public synopsis, not necessarily that no money is available. In many CDC and PEPFAR-related announcements, final award amounts depend on availability of funds, approved budgets, scope negotiations, and geographic coverage, and they may be determined through the continuation review process rather than through a single fixed cap.

In summary, this opportunity represents a CDC/PEPFAR continuation cooperative agreement aimed at maintaining and improving the delivery of HIV/AIDS clinical services across Nigeria, with a deliberate push to engage and empower indigenous organizations to lead implementation. It is structured to support sustained treatment and care outcomes and to strengthen the systems that keep clinical HIV programs functioning effectively, with CDC playing an active technical and programmatic role typical of cooperative agreements.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 06, 2017.
• Applicants must submit their applications by Apr 06, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH12 121005CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: